A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

BACKGROUND: The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing phase 3 trial. We studied infants 6 to 12 weeks of age recruited for the same trial. METHODS: We administered RTS,S/AS01 or a...

Full description

Bibliographic Details
Main Authors:	Agnandji, S, Lell, B, Fernandes, J, Abossolo, B, Methogo, BG, Kabwende, A, Adegnika, A, Mordmüller, B, Issifou, S, Kremsner, P, Sacarlal, J, Aide, P, Lanaspa, M, Aponte, J, Machevo, S, Acacio, S, Bulo, H, Sigauque, B, Macete, E, Alonso, P, Abdulla, S, Salim, N, Minja, R, Mpina, M, Ahmed, S
Format:	Journal article
Language:	English
Published:	2012

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

Similar Items